1 completed, 1 terminated. 1 Early Phase 1, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Rhonda Brand: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Development of a Urine-Based Point-of-Care Test for Adherence to Antiretroviral Drugs dolutegravir oral tablet 50mg, emtricitabine/tenofovir alafenamide oral tablet 200mg/25mg, tenofovir disoproxil fumarate oral tablet 300mg - Medication Adherence, HIV | Early Phase 1 | Completed | Rhonda Brand | 30 | 2020-08-31 | 2022-03-03 |
| Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT) Q-Griffithsin (Q-GRFT) enema, Placebo enema - HIV Prevention | Phase 1 | Terminated | Rhonda Brand | 18 | 2019-07-10 | 2023-07-06 |
Emtricitabine (1) · Enema (1) · Lamivudine (1) · Tenofovir (1) · dolutegravir (1) · emtricitabine tenofovir alafenamide (1) · q-griffithsin (1) · tenofovir alafenamide (1)
United States (2)
Ken Ho, MD (2)
R01AI122301 (1), U19AI113182 (1)